How Multiple Sclerosis Impacts Brain White and Gray Matter

Multiple sclerosis (MS) is a chronic disease of the central nervous system that can damage both the brain’s white matter and gray matter. This dual involvement may lead to a range of neurological symptoms, such as fatigue, memory problems, and other cognitive or physical challenges.

Understanding White Matter vs. Gray Matter

White matter consists of myelinated nerve fibers that transmit signals between different brain regions. Gray matter contains neuronal cell bodies and is responsible for processing information. For many years, research focused mainly on white‑matter lesions in MS, but a 2017 study confirmed that gray‑matter degeneration also occurs, contributing to the disease’s broader impact.

Why Early Treatment Matters

Starting disease‑modifying therapies (DMTs) early can slow or limit damage to both types of tissue. Prompt treatment may reduce the severity of physical symptoms—such as weakness or coordination issues—and lessen cognitive effects like slowed thinking or memory loss.

Therapeutic Options

Several DMTs are available to curb the inflammatory process that drives tissue injury. In addition, symptom‑specific medications and rehabilitation programs (physical therapy, occupational therapy, cognitive training) help manage existing impairments.

Discuss your individual situation with a neurologist to understand how MS may be affecting your brain and to explore the most appropriate treatment plan.